Iferanserin (S-MPEC) is a selective antagonist of the 5-HT receptor (serotonin receptor) with an affinity for 5-HT2A receptors. Iferanserin has the potential for internal hemorrhoid disease treatment.

Iferanserin might modify the vascular effects occurring in hemorrhoid disease when it is used as an intra-anal ointment. Thereby decrease or eliminate the most frequently occurring symptoms of hemorrhoid disease[1].

58754-46-4

C23H28N2O

348.48

S-MPEC;Iferanserin

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years